scholarly journals TOBACCO PRODUCTS: CHEMICAL ANALYSIS AND COMPARATIVE HARMFULNESS

2021 ◽  
Vol 9 (4) ◽  
pp. 777-783
Author(s):  
Sunita Kumari Bijarniya ◽  
Ritu Kapoor ◽  
Manoj Adlakha
Keyword(s):  
Chronic Toxicity ◽  
Tobacco Consumption ◽  
Tobacco Product ◽  
Oral Route ◽  
Basic Knowledge ◽  
Oral Diseases ◽  
Tobacco Products ◽  
Comparative Toxicity ◽  
Adolescent Groups ◽  
Precancerous Stage

Tobacco consumption is a major social health problem in India as well as throughout the world, because it harms both health and wealth of an addict. Tobacco is a Sthavara Patra Visha received from the plant Nicotiana tobacum/ Nicotiana rusticum leaves by curing them. Tobacco contains an alkaloid nicotine in abundant amount, which is sufficient to make addict like alcohol, cocaine and morphine. There are so many different forms of smoking and smokeless tobacco in India, like cigarette, bidi, gutka, jarda, pan masala etc. Long timed use of Tobacco like adductive products by oral route, acts as a slow poison (Dushi Visha) induces chronic toxicity to the gastrointestinal tract like oral diseases, gingivitis and periodontitis, Leukoplakia (precancerous stage), and may lead to cancer also in advance stage. This chronic toxicity affects cardiovascular system and results as increasing coronary blood flow, heart rate and blood pressure which may trigger the chances of heart attack rate in addict person. Before we can do any effort for reducing toxicity produced by tobacco products its mandatory to knowing the basic knowledge of tobacco products, their chemical composition, their mechanism of action with comparative toxicity and specific tobacco product related to a specific mouth part cancer. Because we can’t stop a person to start tobacco use but we can circulate the knowledge of tobacco products in adolescent groups so that when the beginner chose a tobacco product, he will be aware about the toxicity and affecting organ because of its use. So that, the toxicity can be minimised. Keywords: Tobacco consumption, nicotine, slow poison, cancer, comparative toxicity

scholarly journals Trend in the affordability of tobacco products in Bangladesh: findings from the ITC Bangladesh Surveys

2018 ◽  
Vol 28 (Suppl 1) ◽  
pp. s20-s30 ◽  
Author(s):  
Nigar Nargis ◽  
Michal Stoklosa ◽  
Jeffrey Drope ◽  
Geoffrey T Fong ◽  
Anne C K Quah ◽  
...  
Keyword(s):  
Tobacco Use ◽  
Smokeless Tobacco ◽  
Linear Regression Analysis ◽  
Tobacco Consumption ◽  
Tobacco Product ◽  
Price Increase ◽  
Income Growth ◽  
Multivariate Linear Regression Analysis ◽  
Tobacco Products ◽  
Individual Level

BackgroundThe price of tobacco products in relation to the income of tobacco users—affordability—is recognised as a key determinant of tobacco use behaviour. The effectiveness of a price increase as a deterrent to tobacco use depends on how much price increases in relation to the income of the potential users. The aim of this paper is to examine the distribution of and trends in the affordability of tobacco products in Bangladesh.MethodUsing four waves of International Tobacco Control Survey data on Bangladesh, this study measures affordability of tobacco products at the individual level as the ratio of self-reported price and self-reported income. The trends in affordability by brand categories of cigarettes and of bidi and smokeless tobacco are estimated using multivariate linear regression analysis.ResultsDespite significant increase in price, the affordability of cigarettes increased between 2009 and 2014–2015 due to income growth outpacing price increase. The increase was disproportionately larger for more expensive brands. The affordability of bidis increased over this period as well. The affordability of smokeless tobacco products remained unchanged between 2011–2012 and 2014–2015.ConclusionThe tax increases that were implemented during 2009–2015 were not enough to increase tobacco product prices sufficiently to outweigh the effect of income growth, and to reduce tobacco consumption. The findings from this research inform policymakers that in countries experiencing rapid economic growth, significant tax increases are needed to counteract the effect of income growth, in order for the tax increases to be effective in reducing tobacco use.

scholarly journals Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control

2018 ◽  
Vol 27 (Suppl 1) ◽  
pp. s111-s117 ◽  
Author(s):  
Stella A Bialous ◽  
Stanton A Glantz
Keyword(s):  
Harm Reduction ◽  
Tobacco Control ◽  
Tobacco Consumption ◽  
Tobacco Product ◽  
Global Strategy ◽  
Tobacco Products ◽  
Control Policies ◽  
Tobacco Control Policies ◽  
Tobacco Epidemic ◽  
Slow Progress

There has been a global decline in tobacco consumption that, if continued, will negatively impact the tobacco industry’s profits. This decline led the industry to invent and market new products, including heated tobacco products (HTP). HTP are an extension of the industry’s strategies to undermine government’s tobacco regulatory efforts as they are being promoted as part of the solution for the tobacco epidemic. Under the moniker of ‘harm reduction’, the tobacco companies are attempting to rehabilitate their reputation so they can more effectively influence governments to roll back existing tobacco control policies or create exemptions for their HTP. Rolling back tobacco control policies will make it easier for the companies to renormalise tobacco use to increase social acceptability for all their products. When regulations are absent or when loopholes exist in classifying HTP as a tobacco product (thus subject to all tobacco control regulations), the industry’s marketing of HTP is making these products more visible to the public and more accessible. Governments need to ensure that HTP are regulated as tobacco products or drugs and reject partnerships with the tobacco companies to promote ‘harm reduction’. The tobacco companies remain the vector of the tobacco-caused epidemic and cannot be part of the global tobacco control solution.

Demarketing Tobacco Products Strategy to Impact Customers for Social Change

2017 ◽  
Vol 4 (4) ◽  
pp. 16-30
Author(s):  
Neeta Baporikar ◽  
Rosalia Fotolela
Keyword(s):  
Lung Cancer ◽  
Mixed Method ◽  
Sampling Technique ◽  
Tobacco Product ◽  
Societal Change ◽  
Oral Diseases ◽  
Tobacco Products ◽  
Differences Of Opinion ◽  
Negative Side Effects ◽  
The Impact

This article describes how demarketing is a strategy aimed at reducing the demand for the product and thereby the consumption. This strategy is well suited for harmful products though they may have utility in the economics of liquor, drugs, cigars and tobacco products. Many consume cigarettes and chew gutka, which is a tobacco product either as habit, stress reliever or style. The consumption of tobacco products has negative side effects such as lung cancer and oral diseases. Thus, the aim of this article is to reflect on the demarketing strategy of tobacco products adopted in India and to determine the impact on customers in Mysore, Southern India. Mixed method of research was used. The sample was 50 respondents, chosen with an accidental sampling technique to test differences of opinion between customers and non-customers of tobacco products. The findings indicate that demarketing tobacco products has made an impact along with societal change.

scholarly journals Polytobacco product use among current cigarette smokers in Hong Kong, China: results from population surveys (2015–17)

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
S. L. Chau ◽  
M. P. Wang ◽  
Y. Wu ◽  
D. Y. T. Cheung ◽  
A. Kong ◽  
...  
Keyword(s):  
Control Policy ◽  
Tobacco Product ◽  
Cigarette Use ◽  
Related Factors ◽  
Cigarette Smokers ◽  
Tobacco Products ◽  
Product Use ◽  
Younger Age ◽  
Current Cigarette ◽  
Age And Sex

Abstract Background Polytobacco product use is increasingly popular, but little is known about the prevalence, trend, and factors of such use particularly in non-western countries. Method A representative sample of 1139 current cigarette smokers aged 15+ (84.1% male) were telephone interviewed in Tobacco Control Policy-related Surveys in 2015–2017. Information collected included poly-tobacco use (PTU), smoking and socio-demographic characteristics. Associations of current PTU with related factors were analyzed using logistic regression with adjustment for confounders. Prevalence was weighted by age and sex of current cigarette users in the general population. Results Eighty-four point one percent (95% CI 81.4–86.6%) were exclusive cigarette smokers. Fifteen point nine percent (13.4–18.6%) were current polytobacco product users, 12.3% (10.2–14.8%) used one tobacco product and 2.52% (1.59–3.97%) used two tobacco products in addition to cigarette. Cigarette use with cigar was more common (6.28%, 4.75–8.27%), and the least used product with cigarette was e-cigarette (1.05%, 0.44–2.50%). The changes in overall prevalence of PTU by number of products use varied in 3 years. Current PTU was associated with being male (AOR 2.01, 95% CI 1.12–3.61), younger age (AORs range from 1.34–4.65, P for trend < .001) and less ready to quit (2.08, 1.09–3.97). Conclusions Prevalence of PTU increased slowly by year, one tobacco product use with cigarette was more common. The most used tobacco product with cigarette was cigar. Being male, younger and less ready to quit were associated with current PTU.

Patterns of non-cigarette tobacco and nicotine use among current cigarette smokers and recent quitters: Findings from the 2020 ITC Four Country Smoking and Vaping Survey

2021 ◽  
Author(s):  
Lin Li ◽  
Ron Borland ◽  
K Michael Cummings ◽  
Shannon Gravely ◽  
Anne C K Quah ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Cigarette Smoking ◽  
Smoking Status ◽  
Tobacco Product ◽  
Cigarette Tobacco ◽  
Cigarette Smokers ◽  
Tobacco Products ◽  
Patterns Of Use ◽  
Levels Of Use ◽  
Current Cigarette

Abstract Introduction This study explores patterns of use of non-cigarette tobacco and nicotine products among adult cigarette smokers and recent ex-smokers. Along with cigarette smoking status we explore differences as a function of countries with different product regulations, gender and age. Methods Data came from the ITC Four Country Smoking and Vaping Wave 3 Survey conducted between February-June 2020. The analytic sample consisted of 9112 current cigarette smokers (at least monthly) and 1184 recent ex-smokers (quit cigarettes ≤ 2 years) from Australia, Canada, England, and the US. Respondents were asked about their cigarette smoking and current use of the following non-cigarette products: combustible tobacco (cigars, cigarillos, pipe, waterpipe); non-combustible tobacco (smokeless tobacco, and heated tobacco products (HTPs)); and non-tobacco nicotine products (nicotine vaping products (NVPs), nicotine replacement therapy (NRT), and nicotine pouches)). Results Overall, NVPs (13.7%) and NRT (10.9%) were the most reported nicotine products used, followed by cigars (5.3%), cigarillos (4.2%), and HTPs (3.5%). More than 21% current and recent ex-smokers of cigarettes reported using a non-tobacco nicotine product and non-combustible product, with respondents in England reporting the highest levels of use (&gt;26%). Males, younger respondents, and current non-daily cigarette smokers were more likely to use non-cigarette nicotine products. Notably, 11.6% of ex-cigarette smokers were using other combustible tobacco. Conclusion Considerable percentages of current cigarette smokers and ex-smokers use non-cigarette nicotine products, and there are unexpectedly high levels of use of other combustible products by those recent ex-smokers of cigarettes which is concerning and has important implications for definitions of smoking cessation. Implications The tobacco product market has evolved to include new products which add to existing non-cigarette tobacco products creating a much more diverse nicotine market. This brief report provides a snapshot of use of various combustible and non-combustible nicotine containing products among current cigarette smokers and recent ex-smokers in four western countries. Our results indicate that use of non-cigarette tobacco and nicotine products among these cigarette smokers and recent ex-smokers is not low, particularly among males, younger and non-daily cigarette smokers. Use of other combustible tobacco among respondents that recently quit cigarette smoking is concerning and has important implications for definitions of smoking cessation. Increased emphasis on researching non-cigarette nicotine product use is warranted in tobacco control generally and smoking cessation in particular.

scholarly journals Own-price and cross-price elasticities of demand for cigarettes and waterpipe tobacco in three Eastern Mediterranean countries: a volumetric choice experiment

2021 ◽  
pp. tobaccocontrol-2021-056616
Author(s):  
Ali Chalak ◽  
Rima Nakkash ◽  
Niveen M E Abu-Rmeileh ◽  
Yousef S Khader ◽  
Mohammed Jawad ◽  
...  
Keyword(s):  
Choice Experiment ◽  
Mediterranean Region ◽  
Eastern Mediterranean ◽  
Eastern Mediterranean Region ◽  
Tobacco Consumption ◽  
Evidence Base ◽  
Demand Elasticity ◽  
Tobacco Products ◽  
Price Elasticities ◽  
Mediterranean Countries

BackgroundWaterpipe tobacco smoking rates in the Eastern Mediterranean region are among the highest worldwide, yet little evidence exists on its economics. Estimates of demand elasticities for tobacco products are largely limited to cigarettes. This study aimed to estimate own-price and cross-price elasticities of demand for cigarettes and waterpipe tobacco products in Lebanon, Jordan and Palestine.MethodsA volumetric choice experiment was conducted using nationally representative household surveys. The choice experiment elicited respondents’ stated purchases of eight cigarette and waterpipe tobacco product varieties by hypothetically varying prices. Data were analysed using zero-inflated Poisson models that yielded demand elasticity estimates of cigarette and waterpipe tobacco consumption.ResultsThe study included 1680 participants in Lebanon (50% female), 1925 in Jordan (44.6% female) and 1679 in Palestine (50% female). We found the demand for premium cigarettes to be price elastic (range, −1.0 to −1.2) across all three countries, whereas the demand for discount cigarettes was less elastic than premium cigarettes in Lebanon (−0.6) and Jordan (−0.7) and more elastic in Palestine (−1.2). The demand for premium waterpipe tobacco was highly elastic in Lebanon (−1.9), moderately elastic in Jordan (−0.6) and inelastic in Palestine (0.2). The cross-price elasticity between cigarettes and waterpipe tobacco was near zero, suggesting that the two products are not considered to be close substitutes by consumers.ConclusionsThese results serve as a strong evidence base for developing and implementing fiscal policies for tobacco control in the Eastern Mediterranean region that address cigarettes and waterpipe tobacco products.

FDA’s reduced exposure marketing order for IQOS: why it is not a reliable global model

2021 ◽  
pp. tobaccocontrol-2020-056316
Author(s):  
Lauren Kass Lempert ◽  
Stella Bialous ◽  
Stanton Glantz
Keyword(s):  
Public Relations ◽  
Tobacco Control ◽  
Scientific Evidence ◽  
Tobacco Product ◽  
Tobacco Products ◽  
Sales And Marketing ◽  
Philip Morris ◽  
The Us ◽  
The Usa ◽  
The Difference

The US Food and Drug Administration (FDA) issued orders in July 2020 authorising Philip Morris Products S.A. to market its heated tobacco product (HTP) IQOS inside the USA with claims that it reduces exposure to some dangerous substances. FDA’s ‘reduced-exposure’ orders explicitly prohibit the marketing of IQOS with claims that IQOS will reduce harm or the risk of tobacco-related diseases. Under US law, FDA’s IQOS orders are problematic because FDA disregarded valid scientific evidence that IQOS increases exposure to other dangerous toxins and that Philip Morris Products S.A. failed to demonstrate that consumers understand the difference between reduced-exposure and reduced-harm claims. Unfortunately, both ‘reduced-exposure’ and ‘reduced-harm’ are classified as ‘modified risk tobacco products’ under US law. Exploiting this confusion, Philip Morris International used the FDA decision as the basis for marketing and public relations campaigns outside the USA to press governments to reverse policies that ban or regulate the sales and marketing of HTPs, including IQOS. Parties to the WHO Framework Convention on Tobacco Control should reject tobacco companies’ unsubstantiated explicit or implied claims of reduced harm associated with HTPs and resist Philip Morris International’s and other companies’ calls to relax HTP regulations based on the FDA’s actions. Instead, parties should adopt policies aligned with the Framework Convention on Tobacco Control when dealing with HTPs and other novel tobacco products.

scholarly journals Smokeless Tobacco - An Overview

2009 ◽  
Vol 23 (5) ◽  
pp. 248-276 ◽  
Author(s):  
H Klus ◽  
M Kunze ◽  
S Koenig ◽  
E Poeschl
Keyword(s):  
North America ◽  
Tobacco Use ◽  
Smokeless Tobacco ◽  
Tobacco Consumption ◽  
Epidemiological Studies ◽  
Western World ◽  
The European Union ◽  
Oral Diseases ◽  
Pyrolysis Products ◽  
Wide Range

AbstractSmoking, especially cigarette smoking, is the most common form of tobacco consumption world-wide. It is generally accepted that smoking carries health risks for smokers. The combustion and pyrolysis products of tobacco generated during smoking are considered to be responsible for the harmful effects. Smokeless tobacco, another wide-spread form of tobacco use, is not subjected to burning and produces no combustion or pyrolysis products. Therefore, there is an increasingly intense debate about the potential role of smokeless tobacco in reducing the harm of tobacco use.An overview is presented on the different types of smokeless tobaccos consumed around the world. Commercial products differ widely in composition and patterns of use. The smokeless tobaccos of the Western world (Europe and North America) need to be clearly distinguished from those popular in Asia, Africa and South America. The modern smokeless tobaccos used in Europe and North America are reviewed regarding their chemical composition and toxicological properties. Agents of concern found in smokeless tobacco, especially the tobacco specific N-nitrosamines, are dealt with in particular.The epidemiological evidence is summarized concerning a wide range of health outcomes. Published reviews and studies are presented and interpreted regarding non-neoplastic oral diseases, various forms of cancer, circulatory diseases, several other diseases and pregnancy outcome. While many of the epidemiological studies have weaknesses and data are often inconsistent it is quite obvious that smokeless tobacco use is much less risky for consumers than smoking. In fact, for modern forms of European moist snuff such as Swedish snus, which is subject to strict quality standards, there is evidence for - if any - only very limited serious health risk.The ongoing public discussion centers around the influence smokeless tobacco may have on smoking rates (initiation or cessation) and the occurrence of tobacco specific diseases - with Sweden being a revealing example. There is an interesting controversy regarding product and marketing regulations for smokeless tobaccos in the European Union.

scholarly journals Impact of common tobacco products on human health and environmental pollution in Bangladesh

2021 ◽  
Vol 31 (3) ◽  
pp. 130-143
Author(s):  
MA Mondol ◽  
AMM Hosain ◽  
S Sultana ◽  
S Marzia ◽  
MA Islam ◽  
...  
Keyword(s):  
Environmental Pollution ◽  
Human Health ◽  
Smokeless Tobacco ◽  
Tobacco Product ◽  
Tobacco Products ◽  
Face To Face ◽  
Adverse Health Effects ◽  
Survey Results ◽  
Young Smokers ◽  
Structured Questionnaire

Worldwide, tobacco is one of the leading causes of disability and death. Over a million of pounds of toxic chemicals are released by tobacco products. This study aims to explore the effects of tobacco toxicants on human health and environmental pollution. Four districts (Dhaka, Kushtia, Chattogram and Rangpur) were selected where most of the tobacco product grown. Total 468 respondents were interviewed face-to-face using structured questionnaire to assess the knowledge about toxicant content in tobacco and health and environmental hazards of tobacco use. Survey results revealed that about 44.4% respondents used smoking tobacco products and 38.5% used smokeless tobacco, while only 17.1% used both. About two third (74.3%) of smoking tobacco users started smoking when they were between 15 to 24 years old and majority (61.6%) of smokeless tobacco users started tobacco when they were between 30 to 35 years above. Tobacco product has large impacts on health of young smokers. Smokers are suffering from various acute and chronic diseases. Among the respondents, 38% indicated that they were suffering from hypertension. The second most affected disease was COPD/Asthma (31.6%), while cancer was the least suffering disease (0.4%). Majority of the respondents were not aware about the presence of toxicants (i.e. nicotine, tar and metals) in tobacco products. However, 85.1% tobacco users had an idea about environmental pollution. There is a lack of knowledge among the survey respondents about toxicants in tobacco products that are linked to health hazards and environmental pollution. These results are important in strengthening existing policy considering adverse health effects of toxicants examined. Progressive Agriculture 31 (3): 130-143, 2020

Sign in / Sign up

Export Citation Format

Share Document